Literature DB >> 15152086

The dimerization domain of the HIV-1 capsid protein binds a capsid protein-derived peptide: a biophysical characterization.

María T Garzón1, María C Lidón-Moya, Francisco N Barrera, Alicia Prieto, Javier Gómez, Mauricio G Mateu, José L Neira.   

Abstract

The type 1 HIV presents a conical capsid formed by approximately 1500 units of the capsid protein, CA. Homodimerization of CA via its C-terminal domain, CA-C, constitutes a key step in virion assembly. CA-C dimerization is largely mediated by reciprocal interactions between residues of its second alpha-helix. Here, we show that an N-terminal-acetylated and C-terminal-amidated peptide, CAC1, comprising the sequence of the CA-C dimerization helix plus three flanking residues at each side, is able to form a complex with the entire CA-C domain. Thermal denaturation measurements followed by circular dichroism (CD), NMR, and size-exclusion chromatography provided evidence of the interaction between CAC1 and CA-C. The apparent dissociation constant of the heterocomplex formed by CA-C and CAC1 was determined by several biophysical techniques, namely, fluorescence (using an anthraniloyl-labeled peptide), affinity chromatography, and isothermal titration calorimetry. The three techniques yielded similar values for the apparent dissociation constant, in the order of 50 microM. This apparent dissociation constant was only five times higher than was the dissociation constant of both CA-C and the intact capsid protein homodimers (10 microM).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15152086      PMCID: PMC2279969          DOI: 10.1110/ps.03555304

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  43 in total

1.  Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers.

Authors:  R G Maroun; S Gayet; M S Benleulmi; H Porumb; L Zargarian; H Merad; H Leh; J F Mouscadet; F Troalen; S Fermandjian
Journal:  Biochemistry       Date:  2001-11-20       Impact factor: 3.162

2.  Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.

Authors:  S Tang; T Murakami; B E Agresta; S Campbell; E O Freed; J G Levin
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Comparative Quantitative Structureminus signActivity Relationship Studies on Anti-HIV Drugs.

Authors:  Rajni Garg; Satya P. Gupta; Hua Gao; Mekapati Suresh Babu; Asim Kumar Debnath; Corwin Hansch
Journal:  Chem Rev       Date:  1999-12-08       Impact factor: 60.622

4.  Image reconstructions of helical assemblies of the HIV-1 CA protein.

Authors:  S Li; C P Hill; W I Sundquist; J T Finch
Journal:  Nature       Date:  2000-09-21       Impact factor: 49.962

5.  Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide.

Authors:  Z Y Zhang; R A Poorman; L L Maggiora; R L Heinrikson; F J Kézdy
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

6.  C-terminal incorporation of fluorogenic and affinity labels using wild-type and mutagenized carboxypeptidase Y.

Authors:  H R Stennicke; K Olesen; S B Sørensen; K Breddam
Journal:  Anal Biochem       Date:  1997-05-15       Impact factor: 3.365

7.  Facile detection of protein-protein interactions by one-dimensional NMR spectroscopy.

Authors:  Demet Araç; Tara Murphy; Josep Rizo
Journal:  Biochemistry       Date:  2003-03-18       Impact factor: 3.162

Review 8.  Protein-peptide interactions.

Authors:  R L Stanfield; I A Wilson
Journal:  Curr Opin Struct Biol       Date:  1995-02       Impact factor: 6.809

9.  Molecular sieve studies of interacting protein systems. I. Equations for transport of associating systems.

Authors:  G K Ackers
Journal:  J Biol Chem       Date:  1967-07-10       Impact factor: 5.157

10.  Quantitative affinity chromatography. Determination of binding constants by elution with competitive inhibitors.

Authors:  B M Dunn; I M Chaiken
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

View more
  19 in total

1.  Flexibility in HIV-1 assembly subunits: solution structure of the monomeric C-terminal domain of the capsid protein.

Authors:  Luis A Alcaraz; Marta del Alamo; Francisco N Barrera; Mauricio G Mateu; José L Neira
Journal:  Biophys J       Date:  2007-05-25       Impact factor: 4.033

2.  A cell-penetrating helical peptide as a potential HIV-1 inhibitor.

Authors:  Hongtao Zhang; Qian Zhao; Shibani Bhattacharya; Abdul A Waheed; Xiaohe Tong; Anita Hong; Susanne Heck; Francesca Curreli; Michael Goger; David Cowburn; Eric O Freed; Asim K Debnath
Journal:  J Mol Biol       Date:  2008-03-06       Impact factor: 5.469

Review 3.  HIV type 1 Gag as a target for antiviral therapy.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-21       Impact factor: 2.205

4.  Binding of the C-terminal domain of the HIV-1 capsid protein to lipid membranes: a biophysical characterization.

Authors:  Francisco N Barrera; Estefanía Hurtado-Gómez; María C Lidón-Moya; José L Neira
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

5.  Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid.

Authors:  Francesca Curreli; Hongtao Zhang; Xihui Zhang; Ilya Pyatkin; Zagorodnikov Victor; Andrea Altieri; Asim K Debnath
Journal:  Bioorg Med Chem       Date:  2010-11-25       Impact factor: 3.641

Review 6.  HIV-1 gag: an emerging target for antiretroviral therapy.

Authors:  Philip R Tedbury; Eric O Freed
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

7.  Defining the epitope region of a peptide from the Streptomyces coelicolor phosphoenolpyruvate:sugar phosphotransferase system able to bind to the enzyme I.

Authors:  Estefanía Hurtado-Gómez; Olga Abián; F Javier Muñoz; María José Hernáiz; Adrián Velázquez-Campoy; José L Neira
Journal:  Biophys J       Date:  2008-05-02       Impact factor: 4.033

Review 8.  HIV-1 Capsid Inhibitors as Antiretroviral Agents.

Authors:  Suzie Thenin-Houssier; Susana T Valente
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

9.  Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.

Authors:  Suzie Thenin-Houssier; Ian Mitchelle S de Vera; Laura Pedro-Rosa; Angela Brady; Audrey Richard; Briana Konnick; Silvana Opp; Cindy Buffone; Jakob Fuhrmann; Smitha Kota; Blase Billack; Magdalena Pietka-Ottlik; Timothy Tellinghuisen; Hyeryun Choe; Timothy Spicer; Louis Scampavia; Felipe Diaz-Griffero; Douglas J Kojetin; Susana T Valente
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

10.  Protein helical structure determination using CD spectroscopy for solutions with strong background absorbance from 190 to 230nm.

Authors:  Yang Wei; Aby A Thyparambil; Robert A Latour
Journal:  Biochim Biophys Acta       Date:  2014-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.